{"id":"W2278895774","doi":"10.1182/blood.v122.21.5398.5398","title":"Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) For The Treatment Of Secondary Plasma Cell Leukaemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Bortezomib; Thalidomide; Plasma cell leukemia; Dexamethasone; Multiple myeloma; Internal medicine; Gastroenterology; Melphalan; Neutropenia; Toxicity; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002178485,0.0001304471,0.0002826707,0.0003078613,0.0002244859,0.0002694378,0.0001882287,0.0001197496,0.001838606],"category_scores_gemma":[0.000222608,0.00007388619,0.0002094968,0.0003422986,0.0001532301,0.00009074838,0.0002008019,0.0002925832,0.0003094743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003440967,"about_ca_system_score_gemma":0.0004786115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004260028,"about_ca_topic_score_gemma":0.001264213,"domain_scores_codex":[0.9998828,0.00003582451,0.0000206424,0.0000200236,0.00002259074,0.00001805812],"domain_scores_gemma":[0.9998595,0.00003258921,0.00004728508,0.000006304996,0.00000903042,0.00004525501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009371501,0.0008131369,0.4827234,0.001382772,0.000278815,0.03729523,0.0003810712,0.001047345,0.08735227,0.0007347979,0.006936773,0.3716828],"study_design_scores_gemma":[0.001995261,0.02057631,0.6789894,0.0003858196,0.0003406664,0.1852624,0.0003755116,0.002289746,0.02828357,0.0005691826,0.08089613,0.00003602256],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810989,0.01054456,0.001283454,0.0004804465,0.00005389308,0.0002234058,0.0005980936,0.00007611263,0.005641071],"genre_scores_gemma":[0.995886,0.0019044,0.0007137017,0.0001303369,0.00004144342,0.00004104062,0.0003430764,0.000005238511,0.0009346978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001838606,"threshold_uncertainty_score":0.006150723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02664593212057632,"score_gpt":0.2790813283549483,"score_spread":0.2524353962343719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}